Significance of sentinel node biopsy in the treatment of patients with melanoma

Authors

  • O.P. Kabanets Bogomolets National Medical University, Kyiv, Ukraine
  • A.A. Samusieva Bogomolets National Medical University, Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2663-3272.3.2.2020.215661

Keywords:

melanoma, sentinel node biopsy, melanoma metastasis

Abstract

Management strategy for melanoma patients is constantly evolving. Ever since D.L. Morton described sentinel node biopsy, its place in melanoma management is being continuously studied and discussed. Metastasis through the lymphatic system is a complex cascade of processes. Plenty of factors can influence it: patient’s age, localization of the primary tumor, depth of invasion, etc. In this review, we consider clinical value and advisability of sentinel node biopsy, including the evolution of indications for it.

References

Федоренко З.П., Гулка Л.О., Михайлович Ю.Й. та ін. 2020. Рак в Україні, 2018-2019. Бюлетень Національного канцер-реестру України № 21.

Rastrelli M., Tropea S., Rossi C.R. et al. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. 2014. In Vivo. 28(6). 1005-11.

Ellis M.S., Weerasinghe R., Corless C. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. Am. J. Surg. 2010. 199(5). 663-668.

Rousseau D.L., Ross M.I., Johnson M.M. et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann. Surg. Oncol. 2003. 10(5). 569-574.

Moreno-Ramirez D., Tejera-Vaquerizo A., Mendonca F.I. et al. Making decisions on sentinel lymph node biopsy for malignant melanoma: Prioritization of determinants using a decision tree. J. Eur. Acad. Dermatol Venereol. 2017. 31(5). e247-9. doi: 10.1111/jdv.14019.

Verstijnen J., Damude S., Hoekstra H.J. et al. Practice variation in sentinel lymph node biopsy for melanoma patients in different geographical regions in The Netherlands. Surg Oncol. 2017. 26(4). 431-7. doi: 10.1016/j.suronc.2017.08.006.

Oude Ophuis C.M., van Akkooi A.C., Rutkowski P. et al. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival. Eur. J. Cancer. 2016. 67. 164-73. doi: 10.1016/j.ejca. 2016.08.014.

El Sharouni M., Witkamp A.J., Sigurdsson V. et al. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma. Ann. Surg. Oncol. 2019. 26. 1494-1502.

Кудрявцев Д.В., Кудрявцева Г.Т., Гуменецкая Ю.В., Давыдов Г.А., Олейник Н.А., Двинских Н.Ю., Стародубцев А.Л. Биопсия сторожевых лимфатических узлов в профилактике регионарных рецидивов у больных с локализованной меланомой кожи. Вестник рентгенологии и радиологии. 2017. 98(6). С. 303-309. https://doi.org/10.20862/0042-4676-2017-98-6-303-309.

Полуэктова Ю.В. Биопсия сторожевого лимфатического узла при первичной меланоме кожи. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2011. № 3. С. 4-11.

Wong S.L., Faries M.B., Kennedy E.B. et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American society of clinical oncology and society of surgical oncology clinical practice guideline update. J. Clin. Oncol. 2018. 36. 399-413. doi: 10.1200/JCO. 2017.75.7724.

Gyorki D.E., Barbour A., Hanikeri M. et al. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'. Australas J. Dermatol. 2017. 58(4). 274-7. doi: org/10.1111/ajd. 12662.

Ferguson M.K., Huisingh-Scheetz M., Thompson K. et al. The influence of physician and patient gender on risk assessment for lung cancer resection. Ann. Thorac. Surg. 2017. 104(1). 284-9. doi: 10.1016/j.athoracsur.2017.01.066.

Snow H.L. Melanotic cancerous disease. Lancet. 1892. 2. 872.

Morton D.L., Wen D.R., Wong J.H. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. A. J. Arch. Surg. 1992. 127(4). 392-9.

Alex J.C., Krag D.N. Gamma-probe guided localization of lymph nodes. Surg. Oncol. 1993. 3(2). 137-143.

Schuitevoerder D., White I., Fortino J. et al. Axillary web syndrome: an underappreciated complication of sentinel node biopsy in melanoma. American Journal of Surgery. 2016. 211(5). 846-9. doi: 10.1016/j. amjsurg.2016.01.004.

Ferraraa G., Partenzib A., Filosaa A. Sentinel Node Biopsy in Melanoma: A Short Update. Dermatopathology. 2018. 5. 21-25. doi: 10.1159/000484892.

Conic R.Z., Cabrera C.I., Khorana A.A. et al. Determination of the impact of melanoma surgical timing on survival using the National Cancer Database. J. Am. Acad. Dermatol. 2018. 78(1). 40-67. https://doi.org/10.1016/j.jaad.2017.08.039

Kachare S.D., Brinkley J., Wong J.H. et al. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma. Ann. Surg. Oncol. 2014. 21(11). 3377-85. https://doi.org/10.1245/s10434-014-3954-5.

Morton D.L., Thompson J.F., Alistair J. Sentinel Node Bio­psy or Nodal Observation in Melanoma. N. Engl. J. Med. 2006. 13(355). 1307-1317.

Leiter U., Stadler R., Mauch C. et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, rando­mized, phase 3 trial. Lancet Oncol. 2016. 17(6).757-67. https://doi.org/10.1016/S1470-2045(16)00141-8.

Eggermont A.M.M., Robert C., Ribas A. The new era of adjuvant therapies for melanoma. Nat. Rev. Clin. Oncol. 2018. 15. 535-536.

Sarah H. Sentinel lymph node biopsy. Available from: https://dermnetnz.org/topics/sentinel-lymph-node-biopsy. Accessed: 2015.

Campillo A., Martinez-Escribano J.A., Moya-Quiles M.R. et al. Natural killer receptors on CD8 T cell sand natural killer cells from different HLA-C phenotypes in melanoma patients. Clin. Cancer. Res. 2006.

Published

2020-05-01

Issue

Section

Review